Chest pain CT scan: Difference between revisions
Jump to navigation
Jump to search
| (10 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Chest pain}} | {{Chest pain}} | ||
{{CMG}}; {{AE}}{{Aisha}} | {{CMG}}; {{AE}} {{Sara.Zand}} {{Aisha}} | ||
==Overview== | ==Overview== | ||
[[Coronary CT angiography]] ([[CCTA]]) can be helpful to diagnose the extent and severity of [[nonobstructive]] and [[obstructive]] [[CAD]], as well as high-risk features of [[atherosclerotic plaque]] (positive [[remodeling]], [[low attenuation plaque]]). [[ Fractional flow reserve]] with [[CT]] ([[FFR-CT]]) provides additional information about [[ischemia]] related to [[lesion]]. Dosimetry is low for [[CCTA]], with effective doses for most patients in the 3 to 5 mSv range. | |||
==CT scan== | |||
* [[Coronary CT angiography]] ([[CCTA]]) can be helpful to diagnose the extent and severity of [[nonobstructive]] and [[obstructive]] [[CAD]], as well as high-risk features of [[atherosclerotic plaque]] (positive [[remodeling]], [[low attenuation plaque]]). | |||
* [[ Fractional flow reserve]] with [[CT]] ([[FFR-CT]]) provides additional information about an estimation of [[ischemia]] related to [[lesion]]. Radiation dosimetry is low, as 3 to 5 mSv range. | |||
{| class="wikitable" style="margin: 1em auto 1em auto" | |||
!||Favored use of [[Coronary CT Angiography]] ([[CCTA]])|| Favored used of stress imaging | |||
|- | |||
|Aim||Determining obstructive or non-obstructice [[CAD]]||Managing [[ischemia]] | |||
|- | |||
|Likelihood of obstructive [[CAD]]||Age<65 years||Age≥ 65 years | |||
|- | |||
|Previous test|| Inconclusive prior functional study||Inconclusive prior [[CCTA]] | |||
|- | |||
|Other indications||[[Anomalous coronary arteries]], evaluation of [[aorta]], [[pulmonary arteries]]|| Evaluation of [[scar]] or [[microvascular dysfunction]] by [[PET]] or [[stress CMR]] | |||
|- | |||
|} | |||
{| border="5" cellspacing="5" cellpadding="2" | {| border="5" cellspacing="5" cellpadding="2" | ||
|- | |- | ||
! Pretest likelihood [[ | ! Pretest likelihood of [[CAD]] ([[coronary artery disease]]) | ||
|- | |- | ||
| Low risk= Risk stratification of [[ASCVD]], optional [[CAC]] | | Low risk= Risk stratification of [[ASCVD]] ([[atherosclerotic cardiovascular disease]]), optional [[CAC]] ([[coronary artery calcium score]]) | ||
|- | |- | ||
| Intermediate-high risk, younger [[patient]] <65 years, suspected less obstructive [[CAD]] = Favored [[Coronary CT Angiography]] | | Intermediate-high risk, younger [[patient]] <65 years, suspected less obstructive [[CAD]] = Favored [[Coronary CT Angiography]] | ||
| Line 21: | Line 47: | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== | ||
Latest revision as of 13:29, 12 March 2022
|
Chest pain Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chest pain CT scan On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Aisha Adigun, B.Sc., M.D.[3]
Overview
Coronary CT angiography (CCTA) can be helpful to diagnose the extent and severity of nonobstructive and obstructive CAD, as well as high-risk features of atherosclerotic plaque (positive remodeling, low attenuation plaque). Fractional flow reserve with CT (FFR-CT) provides additional information about ischemia related to lesion. Dosimetry is low for CCTA, with effective doses for most patients in the 3 to 5 mSv range.
CT scan
- Coronary CT angiography (CCTA) can be helpful to diagnose the extent and severity of nonobstructive and obstructive CAD, as well as high-risk features of atherosclerotic plaque (positive remodeling, low attenuation plaque).
- Fractional flow reserve with CT (FFR-CT) provides additional information about an estimation of ischemia related to lesion. Radiation dosimetry is low, as 3 to 5 mSv range.
| Favored use of Coronary CT Angiography (CCTA) | Favored used of stress imaging | |
|---|---|---|
| Aim | Determining obstructive or non-obstructice CAD | Managing ischemia |
| Likelihood of obstructive CAD | Age<65 years | Age≥ 65 years |
| Previous test | Inconclusive prior functional study | Inconclusive prior CCTA |
| Other indications | Anomalous coronary arteries, evaluation of aorta, pulmonary arteries | Evaluation of scar or microvascular dysfunction by PET or stress CMR |
| Pretest likelihood of CAD (coronary artery disease) |
|---|
| Low risk= Risk stratification of ASCVD (atherosclerotic cardiovascular disease), optional CAC (coronary artery calcium score) |
| Intermediate-high risk, younger patient <65 years, suspected less obstructive CAD = Favored Coronary CT Angiography |
| Intermediate-high risk, older patient≥ 65 years, suspected more obstructive CAD= Favored Stress Testing |
| The above table adopted from 2021 AHA/ACC/ASE Guideline[1] |
|---|
References
- ↑ Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O'Connor RE, Ross MA, Shaw LJ (November 2021). "2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". Circulation. 144 (22): e368–e454. doi:10.1161/CIR.0000000000001029. PMID 34709879 Check
|pmid=value (help).